McMaster University

McMaster University

St Jospehs Hospital FIRH

Firestone Institute for Respiratory Health (FIRH)

Welcome to the FIRH!

The Firestone Institute is based out of St. Joseph's Healthcare in Hamilton, Ontario, Canada and is affiliated with McMaster University. Clinical, research and educational activities are integrated and largely collaborative within the FIRH. The intent of this institute is to provide optimal patient care through clinical practice, translational research and the training of health care professionals.

Michael T. Newhouse Lecture - October 5, 2015

Please find attached the notice for the Michael T. Newhouse Lecture that is taking place on Monday, October 5th starting with a reception at 5:00pm.

Michael T. Newhouse Lecture - October 5 2015

Here is a summary of the event:

The Michael T. Newhouse Lecture

Monday, October 5th, 2015

Campbell Auditorium

2nd Level Juravinski Innovation Tower

St. Joseph's HealthCare

Reception: 5:00pm

2nd Level Lobby

Lecture: 5:30pm

“What is so precise about Precision Medicine?”

Guest Speaker: Gregory Downey, MD

Executive Vice President for Academic Affairs and

Professor of Medicine and Integrated Department of Immunology

University of Colorado Denver

Dr. O'Byrne - Elected a Fellow

The Canadian Academy of Health Sciences (CAHS) works in partnership with the Royal Society of Canada and the Canadian Academy of Engineering to form the three Member Academies of the Council of Canadian Academies. The academy recognizes the full breadth of academic health science ranging from fundamental science to social science and population health. Fellows elected to the Academy will be well recognized by their peers nationally and internationally for their contributions to the promotion of health science. They will have demonstrated leadership, creativity, distinctive competencies and a commitment to advance academic health science.

Such individuals are elected to the organization after a nominating and peer review procedure that seeks to recognize those who are marked by a record of substantial accomplishment. At the time of election, Fellows must be Canadian citizens or have been Canadian residents for the preceding three years. Election to Fellowship in the Academy is considered one of the highest honours for individuals in the Canadian health sciences community and carries with it a covenant to serve the Academy and the future well being of the health sciences irrespective of the Fellow’s specific discipline.

Fellows of the Academy are entitled to use the designation FCAHS (Fellow of the Canadian Academy of Health Sciences) or MACSS (Membre de l’academie canadienne des sciences de la santé).

Dr. Paul O’Byrne has been elected a Fellow of the Canadian Academy of Health Sciences (CAHS). Considered one of the highest honors for Canadians in the health sciences community, CAHS Fellows are recognized for their innovative leadership, research excellence and commitment to advancing academic health science.

Attached are the elected fellows for 2015.


IPF Awareness Month: Representing the Patient Voice at Queen's Park - Dr. Martin Kolb

IPF Awareness Month - Dr. Martin Kolb - September

In commemoration of IPF Awareness Month, Dr. Martin Kolb (pictured above; centre) was invited by the Canadian Pulmonary Fibrosis Foundation to speak on behalf of patients with idiopathic pulmonary fibrosis (IPF) at Queen’s Park.

The event was held to raise awareness of the disease among legislators and policy-makers – discussing the need for patients to have access to all available treatments. It is estimated that between 10,000-12,000 Canadians are diagnosed with IPF, and half of these patients will only live with the disease for an average of three to four years.

Dr. Kolb met with the Ontario Drug Plan's Executive Officer, Ministry of Health and Long-Term Care representatives, MPPs and stakeholders and discussed the devastating effects of idiopathic pulmonary fibrosis.

His recent research has discovered that two new drugs can slow down the progression of IPF – offering the hope of a longer life to those with the disease. One of these treatments has recently been approved by Health Canada and is currently undergoing evaluation for coverage by OHIP.

New Treatment Offers Hope for an Incurable Disease - Dr. Martin Kolb

New drug slows lung disease idiopathic pulmonary fibrosis by 50 per cent. Attached is an article that appeared in the Hamilton Spectator on August 24, 2015.

New Treatment Offers Hope for an Incurable Disease - Hamilton Spectator Article


Valid XHTML 1.0 Transitional Level Double-A conformance, W3C WAI Web Content Accessibility Guidelines 2.0